BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27566107)

  • 1. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
    Georgescu MM; Gagea M; Cote G
    Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHERF1/EBP50 is a new marker in colorectal cancer.
    Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
    Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
    Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
    J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
    Georgescu MM; Cote G; Agarwal NK; White CL
    Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.
    Oudhoff MJ; Braam MJS; Freeman SA; Wong D; Rattray DG; Wang J; Antignano F; Snyder K; Refaeli I; Hughes MR; McNagny KM; Gold MR; Arrowsmith CH; Sato T; Rossi FMV; Tatlock JH; Owen DR; Brown PJ; Zaph C
    Dev Cell; 2016 Apr; 37(1):47-57. PubMed ID: 27046831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
    Saponaro C; Sergio S; Coluccia A; De Luca M; La Regina G; Mologni L; Famiglini V; Naccarato V; Bonetti D; Gautier C; Gianni S; Vergara D; Salzet M; Fournier I; Bucci C; Silvestri R; Passerini CG; Maffia M; Coluccia AML
    Oncogene; 2018 Jun; 37(24):3301-3316. PubMed ID: 29551770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of Yes-associated protein in colorectal cancer.
    Wang Y; Xie C; Li Q; Xu K; Wang E
    Tumour Biol; 2013 Aug; 34(4):2169-74. PubMed ID: 23558963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
    Fu X; Li L; Peng Y
    J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
    Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
    Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKIα ablation highlights a critical role for p53 in invasiveness control.
    Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
    Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling.
    Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q
    Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in Apc Min mice.
    Marttinen M; Päivärinta E; Storvik M; Huikko L; Luoma-Halkola H; Piironen V; Pajari AM; Mutanen M
    J Nutr Biochem; 2013 Jan; 24(1):343-52. PubMed ID: 22981369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway.
    Zhang QQ; Zhou DL; Lei Y; Zheng L; Chen SX; Gou HJ; Gu QL; He XD; Lan T; Qi CL; Li JC; Ding YQ; Qiao L; Wang LJ
    Oncotarget; 2015 Feb; 6(5):3123-35. PubMed ID: 25605242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
    Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
    Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of NHERF1/EBP50 in cancer.
    Georgescu MM; Morales FC; Molina JR; Hayashi Y
    Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.